These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 12038230)

  • 1. [Arguments for providing blood screening for Down syndrome to all pregnant women].
    Beekhuis JR
    Ned Tijdschr Geneeskd; 2002 May; 146(18):875. PubMed ID: 12038230
    [No Abstract]   [Full Text] [Related]  

  • 2. [Arguments for providing serum screening for Down syndrome for all pregnant women].
    Hamerlynck JV; Knuist M
    Ned Tijdschr Geneeskd; 2002 Mar; 146(12):588-9; author reply 589. PubMed ID: 11938586
    [No Abstract]   [Full Text] [Related]  

  • 3. Options for Down syndrome screening: what will women choose?
    Grant SS
    J Midwifery Womens Health; 2005; 50(3):211-8. PubMed ID: 15894999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum screening of fetal chromosome abnormality during second pregnancy trimester: results of 26,803 pregnant women in Jiangsu Province].
    Hu YL;
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2476-80. PubMed ID: 18067809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in state/population-based Down syndrome screening and invasive prenatal testing with the introduction of first-trimester combined Down syndrome screening, South Australia, 1995-2005.
    Muller PR; Cocciolone R; Haan EA; Wilkinson C; Scott H; Sage L; Bird R; Hutchinson R; Chan A
    Am J Obstet Gynecol; 2007 Apr; 196(4):315.e1-7; discussion 285-6. PubMed ID: 17403402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum screening in pregnant women for Down syndrome and open neural tube defects; testing of Health Council's criteria for genetic screening].
    Beekhuis JR; Mantingh A; Morssink LP; de Wolf BT
    Ned Tijdschr Geneeskd; 1996 Mar; 140(9):506-7, author reply 507-8. PubMed ID: 8628440
    [No Abstract]   [Full Text] [Related]  

  • 7. Are pregnant Australian women well informed about prenatal genetic screening? A systematic investigation using the Multidimensional Measure of Informed Choice.
    Rowe HJ; Fisher JR; Quinlivan JA
    Aust N Z J Obstet Gynaecol; 2006 Oct; 46(5):433-9. PubMed ID: 16953859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated serum screening for Down syndrome in primary obstetric practice.
    Knight GJ; Palomaki GE; Neveux LM; Smith DE; Kloza EM; Pulkkinen AJ; Williams J; Haddow JE
    Prenat Diagn; 2005 Dec; 25(12):1162-7. PubMed ID: 16231402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs and effects of prenatal screening methods for Down syndrome and neural tube defects.
    Hoogendoorn M; Evers SM; Schielen PC; van Genugten ML; de Wit GA; Ament AJ
    Community Genet; 2008; 11(6):359-67. PubMed ID: 18690004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A questionnaire study of women's views regarding the effectiveness of serum Down screening in north west Wales.
    Bulman J; Nan A; Markland MH; Al-Safi W; Leeson S
    J Obstet Gynaecol; 2004 Jan; 24(1):33-9. PubMed ID: 14675978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for all. New guidelines urge every pregnant woman to get early testing for risk of Down syndrome.
    Kotz D
    US News World Rep; 2007 Jan; 142(2):78. PubMed ID: 17225473
    [No Abstract]   [Full Text] [Related]  

  • 12. How important is consent in maternal serum screening for Down syndrome in France? Information and consent evaluation in maternal serum screening for Down syndrome: a French study.
    Favre R; Duchange N; Vayssière C; Kohler M; Bouffard N; Hunsinger MC; Kohler A; Mager C; Neumann M; Vayssière C; Viville B; Hervé C; Moutel G
    Prenat Diagn; 2007 Mar; 27(3):197-205. PubMed ID: 17238219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the current dilemma of Down syndrome screening.
    Rose NC
    Obstet Gynecol; 2006 Jan; 107(1):2-3. PubMed ID: 16394031
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse pregnancy outcomes after a false-positive second trimester serum screen for Down syndrome in Thai pregnant women.
    Sritippayawan S; Vachirasrisoontra C
    J Med Assoc Thai; 2005 Apr; 88(4):449-54. PubMed ID: 16146246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of maternal serum screening programs for Down syndrome in southeast Michigan, 1988-2003.
    Van Dyke DL; Ebrahim SA; Al Saadi AA; Powell SA; Zenger-Hain JL; Micale MA; Wiktor AE; Zou YS
    Prenat Diagn; 2007 Jun; 27(6):583-4. PubMed ID: 17546696
    [No Abstract]   [Full Text] [Related]  

  • 16. [A new offer to all pregnant women: screening for Down syndrome and congenital abnormalities. Danish Society of Obstetrics and Gynecology].
    Tabor A; Uldbjerg N
    Ugeskr Laeger; 2005 Mar; 167(12-13):1399. PubMed ID: 15832719
    [No Abstract]   [Full Text] [Related]  

  • 17. Down syndrome: progress in research.
    Roizen NJ
    Ment Retard Dev Disabil Res Rev; 2001; 7(1):38-44. PubMed ID: 11241881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for Down syndrome: practice patterns and knowledge of obstetricians and gynecologists.
    Cleary-Goldman J; Morgan MA; Malone FD; Robinson JN; D'Alton ME; Schulkin J
    Obstet Gynecol; 2006 Jan; 107(1):11-7. PubMed ID: 16394034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting mothers' knowledge of genetic screening.
    Suriadi C; Jovanovska M; Quinlivan JA
    Aust N Z J Obstet Gynaecol; 2004 Feb; 44(1):30-4. PubMed ID: 15089865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anomalous marker patterns in Down syndrome screening.
    Wald NJ; Bestwick JP; Barnes IM; Kellner LH
    Prenat Diagn; 2007 Feb; 27(2):185-6. PubMed ID: 17266168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.